850 related articles for article (PubMed ID: 3604540)
21. The use of cytology to evaluate pericardial effusions.
King DT; Nieberg RK
Ann Clin Lab Sci; 1979; 9(1):18-23. PubMed ID: 420509
[TBL] [Abstract][Full Text] [Related]
22. The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions.
Kyrkou KA; Iatridis SG; Athanassiadou PP; Athanassiadis PP; Mandragos CE
Cancer Detect Prev; 1985; 8(1-2):247-54. PubMed ID: 4064045
[TBL] [Abstract][Full Text] [Related]
23. An immunoperoxidase study of S-100 protein in neoplastic cells in serous effusions. Use as a marker for melanoma.
Pinto MM
Acta Cytol; 1986; 30(3):240-4. PubMed ID: 3521174
[TBL] [Abstract][Full Text] [Related]
24. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids.
Lee BH; Hecht JL; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2002 May; 117(5):745-50. PubMed ID: 12090423
[TBL] [Abstract][Full Text] [Related]
25. [Cytological variations observed in the malignant cells in body cavity fluids].
Matsuda M
Rinsho Byori; 1990 Nov; Suppl 87():69-85. PubMed ID: 2287091
[No Abstract] [Full Text] [Related]
26. Application of molecular genetics to the diagnosis of lymphoid-rich effusions: study of 95 cases with concomitant immunophenotyping.
Mihaescu A; Gebhard S; Chaubert P; Rochat MC; Braunschweig R; Bosman FT; Delacrétaz F; Benhattar J
Diagn Cytopathol; 2002 Aug; 27(2):90-5. PubMed ID: 12203875
[TBL] [Abstract][Full Text] [Related]
27. Malignancies in Pleural, Peritoneal, and Pericardial Effusions.
Dermawan JKT; Policarpio-Nicolas ML
Arch Pathol Lab Med; 2020 Sep; 144(9):1086-1091. PubMed ID: 31913661
[TBL] [Abstract][Full Text] [Related]
28. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
Yeo KT; Wang HH; Nagy JA; Sioussat TM; Ledbetter SR; Hoogewerf AJ; Zhou Y; Masse EM; Senger DR; Dvorak HF
Cancer Res; 1993 Jun; 53(12):2912-8. PubMed ID: 8504432
[TBL] [Abstract][Full Text] [Related]
29. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Illei PB; Ladanyi M; Rusch VW; Zakowski MF
Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of an antibody to human milk fat globule antigen in the detection of metastatic carcinoma in pleural, pericardial and peritoneal fluids.
Hilborne LH; Cheng L; Nieberg RK; Lewin KJ
Acta Cytol; 1986; 30(3):245-50. PubMed ID: 2424206
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of immunohistochemistry staining and cytologic diagnosis by using cell block sections prepared with effusion fluid cytology specimens].
Mao YY; Yang M; Liu DG; Lin MH; Zhang LQ; Chen ZQ
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):547-50. PubMed ID: 20021967
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and categorization of malignant effusions: A 6-year review from a single academic institution.
Lew M; Cantley R; Heider A; Jing X
Diagn Cytopathol; 2021 May; 49(5):615-621. PubMed ID: 32275354
[TBL] [Abstract][Full Text] [Related]
34. [Preparatory techniques of fluids and screening of malignant cells in effusions].
Nagumo S
Rinsho Byori; 1990 Nov; Suppl 87():191-200. PubMed ID: 2287088
[No Abstract] [Full Text] [Related]
35. Transforming growth factor activity in pleural and peritoneal effusions from cancer and non-cancer patients.
Sairenji M; Suzuki K; Murakami K; Motohashi H; Okamoto T; Umeda M
Jpn J Cancer Res; 1987 Aug; 78(8):814-8. PubMed ID: 3115927
[TBL] [Abstract][Full Text] [Related]
36. Study of effusion cytology in patients with simultaneous malignancy and ascites.
Jha R; Shrestha HG; Sayami G; Pradhan SB
Kathmandu Univ Med J (KUMJ); 2006; 4(4):483-7. PubMed ID: 18603959
[TBL] [Abstract][Full Text] [Related]
37. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
Ciampa A; Fanger G; Khan A; Rock KL; Xu B
Cancer; 2004 Dec; 102(6):368-72. PubMed ID: 15558786
[TBL] [Abstract][Full Text] [Related]
38. Cytogenetic analysis of effusions from malignant mesothelioma. A diagnostic adjunct to cytology.
Granados R; Cibas ES; Fletcher JA
Acta Cytol; 1994; 38(5):711-7. PubMed ID: 8091903
[TBL] [Abstract][Full Text] [Related]
39. Pericellular lacunae in the diagnosis of metastatic carcinoma in effusions: is this a useful sign?
Thomson T; Hayes MM
Diagn Cytopathol; 1996 Sep; 15(3):193-6. PubMed ID: 8955600
[TBL] [Abstract][Full Text] [Related]
40. [Carcinoembryonic antigen in ascites and pleural effusions].
Lirzin P; Zeitoun P; Vandromme L; Salas H
Gastroenterol Clin Biol; 1984 Mar; 8(3):222-7. PubMed ID: 6714557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]